Zoe Quandt, MD

Endocrine Clinical Fellow (MD MS)
Co-Mentor (Mark Anderson)
Medicine
Email: 

Zoe completed her MD at UCSF and her MS in Health and Medical Sciences at UC Berkeley. She completed her residency training in Internal Medicine at Stanford Hospital and Clinics prior to returning to UCSF for her Endocrinology and Diabetes for fellowship. Her research focus is in endocrine immune related adverse events following cancer immunotherapy. She is a recipient of the American Diabetes Association Postdoctoral Fellowship.

Zoe enjoys outdoor adventures and trying out hole-in-the wall restaurants

Publications: 

Chapter 19 Thyroid Disorders During Pregnancy, Postpartum, and Lactation.

Zoe E. Quandt, Kirsten E. Salmeen, Ingrid J. Block-Kurbisch

Elastase 3B mutation links to familial pancreatitis with diabetes and pancreatic adenocarcinoma.

The Journal of clinical investigation

Moore PC, Cortez JT, Chamberlain CE, Alba D, Berger AC, Quandt Z, Chan A, Cheng MH, Bautista JL, Peng J, German MS, Anderson M, Oakes SA

Checkpoint inhibitor-induced insulin-dependent diabetes: an emerging syndrome.

The lancet. Diabetes & endocrinology

Perdigoto AL, Quandt Z, Anderson M, Herold KC

The Balancing Act between Cancer Immunity and Autoimmunity in Response to Immunotherapy.

Cancer immunology research

Young A, Quandt Z, Bluestone JA

Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors.

Diabetes

Stamatouli AM, Quandt Z, Perdigoto AL, Clark PL, Kluger H, Weiss SA, Gettinger S, Sznol M, Young A, Rushakoff R, Lee J, Bluestone JA, Anderson M, Herold KC

Phase 2 trial of pembrolizumab (PEM) plus granulocyte macrophage colony stimulating factor (GM-CSF) in advanced biliary cancers (ABC): Clinical outcomes and biomarker analyses.

Journal of Clinical Oncology

Robin Kate Kelley, Emily Mitchell, Spencer Behr, Jimmy Hwang, Bridget Keenan, Sarah E Umetsu, John Dozier Gordan, Andrew H. Ko, Pelin Cinar, Chloe Evelyn Atreya, Katherine Van Loon, Thomas Weber, Zoe Ngo, Zoe E. Quandt, Chienying Liu, Alan P. Venook, Lawrence Fong

Phase II trial of pembrolizumab (PEM) plus granulocyte macrophage colony stimulating factor (GM-CSF) in advanced biliary cancers (ABC).

Journal of Clinical Oncology

Robin Kate Kelley, Emily Mitchell, Spencer Behr, Jimmy Hwang, Bridget Keenan, Alexander Cheung, John Dozier Gordan, Andrew H. Ko, Pelin Cinar, Chloe Evelyn Atreya, Katherine Van Loon, Thomas Weber, Zoe Ngo, Zoe E. Quandt, Chienying Liu, Alan P. Venook, Lawrence Fong

Spontaneous tumor lysis syndrome in a patient with metastatic prostate cancer.

Molecular and clinical oncology

Serling-Boyd N, Quandt Z, Allaudeen N

The association of alcohol consumption with mammographic density in a multiethnic urban population.

BMC cancer

Quandt Z, Flom JD, Tehranifar P, Reynolds D, Terry MB, McDonald JA

Association of age, stature, and education with ocular dimensions in an older white population.

Archives of ophthalmology (Chicago, Ill. : 1960)

Lee KE, Klein BE, Klein R, Quandt Z, Wong TY